The relationship between serum LDL-cholesterol, HDL-cholesterol and systolic blood pressure in patients with type 2 diabetes

Kardiologia Polska

Volumn 64, Issue 12, 2006, Pages 1364-1368

  Nasri, Hamid ^a   Yazdani, Mohammad ^b  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cholesterol; Diabetes; Hypertension

Indexed keywords

AMLODIPINE; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE;

EID: 33845777059     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992; 19: 403-18.
2. Williams B. Insulin resistance; the shape of things to come. Lancet 1994; 344: 521-4.
3. Vasovic O, Zamaklar M, Lalic K, et al. The prevalence of hypertension and microalbuminuria in diabetes mellitus type 1 and type 2. Srp Arh Celok Lek 2005; 133: 229-32.
4. Cushman WC. The clinical significance of systolic hypertension. Am J Hypertens 1998; 11: 182S-185S.
5. Lackland DT, Egan BM. The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci 1999; 318: 365-8.
6. Arauz-Pacheco C, Parrott MA, Raskin P. Treatment of hypertension in adults with diabetes. Diabetes Care 2003; 26 Suppl 1: S80-2.
7. Tomlinson JW, Owen KR, Close CF. Treating hypertension in diabetic nephropathy. Diabetes Care 2003; 26: 1802-5.
8. Sesso HD, Buring JE, Chown MJ, et al. A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med 2005; 165: 2420-7.
9. Lopes HF, Silva HB, Soares JA, et al. Lipid metabolism alterations in normotensive subjects with positive family history of hypertension. Hypertension 1997; 30: 629-31.
10. Agata J, Miyazaki Y, Takada M, et al. Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension. Hypertens Res 1998; 21: 57-62.
11. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-94.
12. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-26.
13. Hypertension control. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1996; 862: 1-83.
14. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
15. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
17. Wood D, De Backer G, Faergeman O, et al. Prevention of coronary heart disease in clinical practice. Eur Heart J 1998; 19: 1434-503.
18. Nyarko A, Adubofour K, Ofei F, et al. Serum lipid and lipoprotein levels in Ghanaians with diabetes mellitus and hypertension. J Natl Med Assoc 1997; 89: 191-6.
19. Lüscher TF, Boulanger CM, Yang Z, et al. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993; 87 (suppl V): V36-V44.
20. Van der Linde NA, Sijbrands EJ, Boomsa F, et al. Effect of low-sensity lipoprotein cholesterol on angiotensin II sensitivity. A randomized trial with fluvastatin. Hypertension 2006; 47: 1125-30.
21. John S, Delles C, Klingbeil AU, et al. Low-density lipoprotein- cholesterol determines vascular responsiveness to angiotensin II in normocholesterolaemic humans. J Hypertens 1999; 17: 1933-9.